The Effective Blood Concentration of Ciprofol
Recruiting now
Conditions studied: Thyroid Disease
In brief
1. Eligible patients were selected and enrolled in the study. 2. General anesthesia was induced using ciprofol in all participants, with standardized evaluation of consciousness levels during induction. 3. The patients' pain and cognition are followed up after surgery.
Key facts
- Study ID
- NCT07294989
- Run by
- Peking University Shenzhen Hospital
- People needed
- 101
- Starts
- 2025-07-01
- Expected to finish
- 2026-06-30
- Last updated by the study team
- 2026-01-06
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients aged 18-65 years
- Scheduled for elective thyroidectomy
- ASA physical status classification I-II
- Willing to participate and providing written informed consent
You may not qualify if…
- Recent use of sedatives or opioid analgesics
- Severe hepatic or renal dysfunction defined as:Child-Pugh class C (score ≥10), Creatinine clearance <35 mL/min ,Requiring preoperative dialysis
- Significant cardiovascular comorbidities
- Body mass index ≥35 kg/m² or <18.5 kg/m²
- Known hypersensitivity or adverse reactions to propofol/ciprofol
- Neuropsychiatric disorders including:Alzheimer's disease,History of cerebrovascular events,Traumatic brain injury,Space-occupying brain lesions,Other significant neurological deficits
Where it is running
- Peking University Shenzhen Hospital — Shenzhen, Guangdong, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.